Shane Kovacs
2022 - Olema Pharmaceuticals
In 2022, Shane Kovacs earned a total compensation of $2.3M as Chief Operating and Financial Officer at Olema Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $217,800 |
|---|---|
| Option Awards | $1,193,010 |
| Salary | $495,000 |
| Stock Awards | $354,900 |
| Other | $13,370 |
| Total | $2,274,080 |
Kovacs received $1.2M in option awards, accounting for 52% of the total pay in 2022.
Kovacs also received $217.8K in non-equity incentive plan, $495K in salary, $354.9K in stock awards and $13.4K in other compensation.
Rankings
In 2022, Shane Kovacs' compensation ranked 1,577th out of 5,542 executives tracked by ExecPay. In other words, Kovacs earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,577 out of 5,542 | 72nd |
Division Manufacturing | 802 out of 3,000 | 73rd |
Major group Chemicals And Allied Products | 313 out of 1,350 | 77th |
Industry group Drugs | 290 out of 1,253 | 77th |
Industry Pharmaceutical Preparations | 206 out of 907 | 77th |
Source: SEC filing on April 26, 2024.
Kovacs' colleagues
We found two more compensation records of executives who worked with Shane Kovacs at Olema Pharmaceuticals in 2022.